Related Experiment Video
Updated: Jul 15, 2026
08:20
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
New concepts in vaccine development in malaria
Bernard N Kanoi1, Thomas G Egwang
1Medical Biotechnology Laboratories, Kampala, Uganda.
Current Opinion in Infectious Diseases
|May 2, 2007
Summary
Whole attenuated sporozoite vaccines show renewed promise for malaria prevention, despite facing significant development hurdles. Discovering new subunit vaccine candidates and improving long-lasting immunity are crucial for future malaria vaccine progress.
Area of Science:
- Vaccinology
- Parasitology
- Infectious Diseases
Background:
- Malaria remains a significant global health challenge, necessitating innovative vaccine strategies.
- Current vaccine development faces limitations in candidate discovery and achieving long-lasting immunity.
Purpose of the Study:
- To review recent novel concepts and advancements in malaria vaccine development.
- To highlight promising new approaches and ongoing challenges in the field.
Main Methods:
- Review of current literature on malaria vaccine research.
- Analysis of emerging vaccine platforms and candidate discovery strategies.
Main Results:
- Whole attenuated sporozoite vaccines (irradiated or genetically modified) demonstrate consistent protection but face practical challenges.
- Limited Plasmodium falciparum protein candidates are in development; reverse vaccinology and genome-wide surveys are key for discovery.
- Vaccines targeting placental malaria are advancing, with identified PfEMP1 epitopes.
- Live bacterial and viral vectors show potential for vaccine delivery.
Conclusions:
- Attenuated sporozoite vaccines are regaining prominence in malaria vaccine research.
- There is a critical need for identifying more subunit vaccine candidates.
- Developing surrogate markers of immunity and vaccines inducing long-lasting protection are essential goals.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.